1 / 28

Symptom Control in Palliative Care

Symptom Control in Palliative Care. Cathy Corden GP VTS ST1. Case Study 1. Mrs AB 68 year old lady Ca breast with metastatic disease Worsening pain in back, cannot get comfortable at all Nauseous, lethargic and her daughter feels she has become more confused recently.

clint
Download Presentation

Symptom Control in Palliative Care

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Symptom Control in Palliative Care Cathy Corden GP VTS ST1

  2. Case Study 1 • Mrs AB 68 year old lady • Ca breast with metastatic disease • Worsening pain in back, cannot get comfortable at all • Nauseous, lethargic and her daughter feels she has become more confused recently. • On paracetamol 1 gram qds, codeine 30mg qds

  3. Case Study 1 • What are the main issues in this case? • What investigations might you want to carry out? • Is there anything else you would want to know to help make decisions? • If all investigations normal, what would be the next management steps for pain control?

  4. Spinal Cord Compression • Back pain most often thoracic • Weakness of lower limbs • Sensory level • Urinary symptoms Up to 5% cancer sufferers Ca prostate, breast, bronchus, myeloma

  5. Spinal Cord Compression http://intqhc.oxfordjournals.org/content/19/6/377.full

  6. Spinal Cord Compression cont • GP can start dexamethasone 16mg/day whilst referring urgently to oncology/spinal centre • MRI scan • Radiotherapy • Spinal surgery

  7. Hypercalcaemia • 10-20% advanced cancer • Myeloma, breast, renal, squamous cell carcinomas • Nausea, vomiting, confusion, constipation, thirst, fits, coma. • More commonly caused by parathyroid hormone-related peptide secreting tumour rather than lytic metastases

  8. Hypercalcaemia cont • Symptoms appear when calcium rises quickly and over 3.0 mmol/L • Admit for fluids and IV bisphosphonates • May require PO bisphosphonates to reduce recurrence rates.

  9. Bony metastases • Significant pain • Pathological fractures • Analgesia • Radiotherapy • Bisphosphonates • Surgical inj steroids/anaesthetics

  10. WHO analgesic ladder

  11. Opioid Analgesia • Immediate release e.g. oramorph. Work within 20mins and last 4 hours. • Modified release e.g. Zomorph, MST MR. • Start 10 mg immediate release 4 hourly and increase by 30-50% every 3 days until pain relief achieved/SEs. Beware elderly pts.

  12. Opioid Analgesia • Once stable pain control transfer to modified release preparation. • Need immediate release preparation for breakthrough pain. Should be 1/6 total dose e.g. if taking 60 mg MST bd would need 20 mg oramorph 4 hourly. • Remember the laxative, antiemetic

  13. Case Study 2 Mrs CD 56 year old lady Metastatic ovarian carcinoma Continuous vomiting last 4 days Intermittant bowel obstruction. Last opened bowels 3 days ago. Abdominal pain On MST 60 mg bd, oramorph prn, metoclopramide 10mg tds PO Wishes not to go back to hospital as does not want NG tube/prolonged hospital stay

  14. Case Study 2 • You decide to set up a syringe driver at home. • What are the common reasons for using syringe driver? • What medications could you choose, what dosages? • As a GP how do you order syringe drivers? What is the important info needed on prescription?

  15. Syringe Drivers • Persistent vomiting • Reduced level consciousness • Weak • Dysphagia • Forgets to take PO medication • Last days of life

  16. Pain Control • Diamorphine s/c • To convert from oral morphine to s/c diamorphine ratio is 3:1 • On MST 60 mg bd, 40 mg oramorph in 24 hours therefore total morphine 160 mg. Diamorphine dose in 24 hours would be just over 50mg.

  17. Vomiting www.yorkshire-cancer-net.org.uk/

  18. Ordering Syringe Drivers • Medication in words and numbers if controlled drugs • Made up to 15 ml with water for injection • To run over 24 hours • Aseptic services – part of pharmacy • D/W district nurses • Need to sign pink form for DN to set up driver.

  19. Syringe Drivers • Diamorphine can be combined with any of the following in a driver: • Cyclizine • Haloperidol • Hyoscine Hydrobromide • Hyoscine Butylbromide • Levomepromazine • Metoclopramide • Midazolam

  20. Case Study 3 • 79 year old gentleman • Ca bronchus • Struggling with dyspnoea. His wife tells you that he has been deteriorating rapidly last two days and is now very agitated. • On home oxygen

  21. Case Study 3 • What are the common causes of dyspnoea in someone who is palliative? • How would you manage a patient such as this? Consider: • - dyspnoea • - agitation

  22. Dyspnoea • Uncomfortable awareness of breathing. Frightening. • Common in end stage COPD, cardiac failure, cancer, neurological conditions • Rule out COPD exacerbation, PE, pulmonary oedema, pneumonia, SVCO, anaemia, pleural effusion, ascites, lung mets, lymphangitis carcinomatosa

  23. Superior Vena Caval Obstruction • SOB • Swelling face, arms • Collateral veins • Dizziness • Visual changes • Headache • Urgent referral with high dose dexamethasone http://www.bmj.com/content/315/7121/1525.extract

  24. Dyspnoea • O2 • Optimise bronchodilators in COPD • Use fan/open window to ease sensation • Position upright • Physiotherapy • Good oral care

  25. Dyspnoea • Oramorph 2.5 mg 4 hourly. Titrate up. Not used enough for dyspnoea for fear of respiratory depression. However very effective. • Diamorphine s/c • Midazolam 2.5 mg s/c anxiety/fear suffocation.

  26. Agitation • Pain • Urinary retention • Constipation • Anxiety • Uncomfortable positioning • Nausea/vomiting • SE medication • Cerebral irritation

  27. Agitation • Once all above reversible causes have been excluded likely terminal agitation. • Levomepromazine 12.5-25.0 mg s/c 4-6 hourly, 25-150 mg s/c 24 hours. • Midazolam 2.5-5.0 mg s/c 4 hourly, 10-60mg s/c 24 hours.

  28. References • Oxford Handbook of Palliative Care • Derby Hospitals: Syringe Driver Combinations from CASU • www.bathgped.co.uk/presentations • www.yorkshire-cancer-net.org.uk/

More Related